CORS Conference 2020 (online): Pandemics as driver for regulatory innovation - regulatory changes in times of disaster
23-11-2020 09:00 - 12:30
Copenhagen Centre for Regulatory Science, Biopeople
The regulatory world is currently under immense pressure, with global expectations to approve the long-awaited cure against COVID-19 as fast as possible. At the same time as the regulatory system is pushed to the limit, it innovates and instigates changes to accommodate fast patient access to treatment. In this year’s conference, we will focus on how pandemics foster regulatory innovation. Themes to be addressed include the use of novel data techniques, such as artificial intelligence to be applied in regulatory decision-making, as well as communication of uncertainties and benefit/risk evaluation of medicines.
How have these been used in time of regulatory pressure? What can we learn from the exceptional circumstances? And what regulatory innovations should we take forward?
Confirmed speakers and moderators:
- Melanie Carr (European Medicines Agency)
- Kristoffer Albris (Department of Anthropology, University of Copenhagen)
- Andrea Julsing Keyter (South African Health Products Regulatory Authority)
- Frederic Bouder (Department of Safety, Economics and Planning, University of Stavanger)
- Jesper Kjaer (Danish Medicines Agency)
- François Houÿez (EURORDIS)
- Theis Lange (Department of Public Health, University of Copenhagen)
- Lisa Storm Villadsen (Department of Media, Cognition and Communication, University of Copenhagen)
The Conference will take place online and is free of charge for all participants.
CORS would like to invite stakeholders from all backgrounds, academia, industry, and regulatory agencies.
The CORS Annual Conference Committee (from CORS Scientific Advisory Board): Marieke De Bruin (CORS), Per Helboe (Adjunct Professor in Regulatory Science, Faculty of Health and Medical Sciences), Nina Christiansen (LEO Pharma A/S, Global Regulatory Affairs), Per Spindler (Biopeople).
The Copenhagen Centre for Regulatory Science (CORS) aims at being the international partner for academic leadership in regulatory science, research and education and to participate in building the regulatory framework that will make innovative medicinal products available to patients.
Through research and education in regulatory science, CORS improves the drug regulatory system and thereby contributes to an improvement of the health of the society and sustainable drug innovation.
CORS has ambitions in the following subdomains:
- Methodologicalresearch: Strengthening Regulatory Science as an established scientific discipline.
- Appliedregulatory science: Stimulating a sustainable regulatory system, by systematically studying its structure and behavior, as well as designing new tools to facilitate regulatory decision-making.
- Valorisation: Increasing societal relevance of research by utilizing the inter-disciplinary and cross-sectorial setup of CORS.
- Education: Cultivating the regulatory environment for pharmaceutical innovations and emerging technologies.
Partners of CORS are faculties of University of Copenhagen (Health and Medical Sciences, Law, Humanities, Social Sciences), Biopeople, the Danish Medicines Agency, Novo Nordisk A/S, LEO Pharma A/S, H. Lundbeck A/S and Ferring Pharmaceuticals A/S.